The disposition, at a price of $67.37, resulted in William Foote bringing total 16415 shares. Following the acquisition, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. (NASDAQ:WBA) by 3.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. Walgreens Boots Alliance, Inc. has a twelve month low of $63.82 and a twelve month high of $88.00. (NASDAQ:WBA) on November 14, 2017 saw a modest increase, closing the day at $70.37, or a increase of $0.22 or (0.31%).Volume levels waned and WBA actually managed a declined which translated to 5.26 million shares changing hands on the day. The sales growth of the company is 5.30% at the moment, indicating the average sales volume of the company's products and services that have typically improved year-to-year. With the constructive P/E value of Walgreens Boots Alliance, Inc., the investors are able to forecast the positive earnings growth of the company. Quick and current ratio is valued at 0.6 and 1.1 respectively.
Walgreens Boots Alliance, Inc. has a consensus outperform rating from 24 Wall Street analysts, and the number of shares now sold short amount to at least 2.46% of shares outstanding. The pharmacy operator reported $1.31 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.21 by $0.10. Revenue during the quarter was $30.15 billion, representing 5% growth from $28.64 billion in year-ago quarter. Analysts have placed a $86.65 price target on Walgreens Boots Alliance, Inc., suggesting a 22.75% gain from recent close. The company's revenue was up 5.3% compared to the same quarter a year ago. During the same quarter in the prior year, the firm earned $1.07 EPS. Shareholders of record on Monday, November 13th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th.
Taking a look at insider trading at Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. Stock repurchase programs are generally an indication that the company's leadership believes its shares are undervalued.
Some CVS pharmacies are blocking prescription refills, exec blames 'internal network' issues
This led to a lot of angry customers who were told they could fill their prescriptions despite the glitch but actually could not. As of Wednesday morning, CVS had cleared the problem and will continue to investigate the cause of the issue, according to Mr.
WARNING: "Walgreens Boots Alliance, Inc". The original version of this article can be read at https://www.dispatchtribunal.com/2017/11/15/walgreens-boots-alliance-inc-wba-pt-set-at-93-00-by-jefferies-group-llc.html.
A number of other research firms also recently weighed in on WBA. Pivotal Research lowered their price target on Walgreens Boots Alliance from $85.00 to $73.00 and set a "hold" rating on the stock in a report on Tuesday, October 24th. Needham & Company LLC reiterated a buy rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. BidaskClub downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating in a research note on Tuesday, September 12th. Finally, Royal Bank Of Canada reaffirmed a "buy" rating and issued a $88.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the company. They issued a buy rating and a $95.00 target price on the stock.
Other institutional investors and hedge funds have also made changes to their positions in the company. Westside Investment Management Inc. boosted its stake in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator's stock worth $102,000 after acquiring an additional 125 shares in the last quarter. Birinyi Associates Inc. lifted its holdings in Walgreens Boots Alliance by 9.0% in the second quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator's stock worth $105,000 after acquiring an additional 1,239 shares in the last quarter. Reilly Financial Advisors LLC boosted its stake in Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator's stock worth $107,000 after acquiring an additional 100 shares in the last quarter. Waldron LP grew its holdings in Walgreens Boots Alliance by 67.7% during the first quarter. The fund owned 36,655 shares of the pharmacy operator's stock after selling 4,772 shares during the period.
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise.
- Earnings Analysis Of Franklin Resources, Inc. (BEN)
- Guns N' Roses Jam Classic Song With Dave Grohl
- Tyrese's Ex-Wife Went To Court Claiming He Has A 'Mental Illness'
- Former City workers launch debit card for cryptocurrencies
- 'Breakthrough' breast cancer drugs approved
- Sports Illustrated TV streaming service may be unveiled tomorrow
- Dar no more remains approver in Hudaibiya Paper Mills case, indicted again
- Q Poll: Support for gun buy background check at all-time high
- Celebrities React to the Death of Lil Peep
- Moon, Xi restore bilateral ties